Custom Search

Risperidone News

Lingual Lesions With Orally Disintegrating Risperidone

There are reports of oral lesions occurring with the use of orally disintegrating atypical antipsychotic tablets. The reports of adverse reactions caused by orally disintegrating olanzapine indicate that mouth ulcerations and...

Irritability associated with autism: Risperdal approved

The FDA ( Food and Drug Administration ) has approved Risperdal ( Risperidone ) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents. The...

Ranbaxy receives tentative US FDA approval to market Risperidone oral solution

Ranbaxy Laboratories Limited (RLL) has received tentative approval from the US Food and Drug Administration (US FDA) to manufacture and market Risperidone oral solution (1 mg/ml).

Ranbaxy signs licensing & supply agreement for the Canadian market

Ranbaxy Laboratories Ltd has announced that the Company’s wholly owned subsidiary, Ranbaxy Pharmaceuticals Canada Inc. (RPCI) and Janssen-Ortho Inc. (JOI), have entered into a licensing and supply agreement for a generic version...

Antipsychotic Drug May Be Linked to Pituitary Tumors

A link may exist between the development of pituitary tumors and the use of some drugs commonly used to treat schizophrenia, according to research from Duke University Medical Center and the U.S. Food and Drug Administration...

Displaying results 26 to 30 out of 37

< Previous








Next >

Use of this site is subject to the following terms of use